ATAI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
AtaiBeckley Inc (ATAI) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company has strong growth potential in the psychedelics sector, supported by analyst optimism, significant insider and hedge fund buying, and a promising pipeline of innovative treatments. Despite short-term price weakness, the long-term outlook is favorable.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 51.617, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), suggesting short-term downward pressure. Key support is at 3.428, with resistance at 4.069. The stock closed at 3.8499999999999996, slightly above the pivot point of 3.748.
Hedge funds and insiders are significantly increasing their buying activity.
Analysts have issued Buy ratings with high price targets ($11 and $16), citing the company's leadership in next-generation psychiatry and promising clinical assets.
Revenue growth of 1772.50% YoY in Q3 2025 demonstrates strong business momentum.
Potential rescheduling of marijuana could provide additional growth momentum for psychedelics stocks.
The stock is in a short-term downtrend, with bearish moving averages.
Execution risks in the psychedelics sector remain a concern, as highlighted in recent news.
The company is still operating at a net loss (-$61.07M in Q3 2025), though losses are narrowing.
In Q3 2025, AtaiBeckley achieved remarkable revenue growth of 1772.50% YoY to $749,000. Net income improved by 132.34% YoY to -$61.07M, and EPS increased by 75% YoY to -0.28. Gross margin remained at 100%. These metrics indicate significant progress, though the company is not yet profitable.
Analysts are highly optimistic, with recent Buy ratings from Guggenheim and JonesResearch. Price targets range from $11 to $16, reflecting confidence in the company's innovative pipeline and market opportunities in treatment-resistant depression.
